We specialise in a wide range of modalities typically used to produce innovative anti-cancer treatments, including antibody drug conjugates (ADCs) and monoclonal antibodies (mAbs). Our dedicated staff helps get your drug product released quickly and efficiently.
Compare the mechanisms of traditional anticancer drugs with the next generation of therapeutics in this new article written by Commercial Director David Collins. David discusses the new emerging modalities designed to elicit improved targeted efficacy whilst reducing side effects for patients.
Symbiosis are the leading fast access CMO for clinical or small scale commercial manufacture and our offering is built upon the following principles:
We understand that in order to support clinical development of anti-caners, aseptic manufacturers must perform fill/finish within strict timeframes. Our experienced teams work collaboratively with you to facilitate your oncology therapeutic batches.
Get in touch to explore how we are positioned to assist you.
Antibody-drug conjugates (ADCs) are a rapidly emerging class of therapeutic agents that combine the target specificity of a monoclonal antibody (mAb) with the lethality of a cytotoxic payload. With ongoing advancements in drug engineering and fresh biologic insight into mechanisms of drug action, the ADC field is still early in its evolution but represents an exciting opportunity in the fight against cancer. In this infographic, we explore their importance as an advancing treatment and how manufacturing is revolutionizing the treatment of solid tumors.
We have extensive experience in taking precious, complex drug products from manufacture to QP release.
Overcome your development and manufacturing challenges with a partner that has the experience and capabilities to handle your highly potent ADC
Clinical and small scale commercial manufacturing of advanced therapeutics such as viral vectors for cell and gene therapies, oncolytic viruses and critical raw materials such as plasmids.
Symbiosis can support with challenging manufacturing and handling requirements that need specialist knowledge and experience.
Extensive experience in delivering hundreds of projects allowing us to support your clinical trials.
Symbiosis has provided GMP manufacturing across a wide range of small molecule applications, including highly potent materials requiring specialist handling.